American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines
- PMID: 30140139
- PMCID: PMC6092890
- DOI: 10.2337/ds18-0009
American Association of Clinical Endocrinologists/American College of Endocrinology Management of Dyslipidemia and Prevention of Cardiovascular Disease Clinical Practice Guidelines
Abstract
In Brief In February 2017, the American Association of Clinical Endocrin-ologists and the American College of Endocrinology published updated "Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease." The update encompassed recent important clinical trial outcomes and additional research related to the treatment of dyslipidemia. This article summarizes key recommendations from this important guideline.
References
-
- Jellinger PS, Handelsman Y, Rosenblit PD, et al. . American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease. Endocr Pract 2017;23(Suppl. 2):1–87 - PubMed
-
- Bild DE, Bluemke DA, Burke GL, et al. . Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 2002;156:871–881 - PubMed
-
- McClelland RL, Jorgensen NW, Budoff M, et al. . 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J Am Coll Cardiol 2015;66:1643–1653 - PMC - PubMed
-
- Cannon CP, Blazing MA, Giugliano RP, et al. . Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 2015;372:2387–2397 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
